DiaSorin S.p.A Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	25
ISBN Number	not applicable
Product Code	GMD04697

Price

£505.00
approximately: $750 | €594

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a DiaSorin S.p.A's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - In Vitro Diagnostics
3 DiaSorin S.p.A Pipeline Products
- 3.1 DiaSorin S.p.A Product Pipeline Analysis
  - 3.1.1 DiaSorin S.p.A Pipeline Products By Equipment Type
  - 3.1.2 DiaSorin S.p.A Pipeline Products By Development Stage
  - 3.1.3 DiaSorin S.p.A Pipeline Products By Therapy Area
- 3.2 LIAISON 25-OH Vitamin D TOTAL assay-Automated
  - 3.2.1 Product Description
  - 3.2.2 Product Status
- 3.3 LIASION Osteocalcin
  - 3.3.1 Product Description
  - 3.3.2 Product Status
- 3.4 New version of LIASION testosterone
  - 3.4.1 Product Description
  - 3.4.2 Product Status
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Company Statement
9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
10 Recent Developments
- 10.1 Financial Announcements
  - 10.1.1 Feb 29, 2008: AOSL Declares 2007 Preliminary Results
  - 10.1.2 Apr 01, 2007: AOSL Declares 2006 Results
11 Appendix
- 11.1 Methodology
  - 11.1.1 Coverage
  - 11.1.2 Secondary Research
  - 11.1.3 Primary Research
  - 11.1.4 Expert Panel Validation
- 11.2 Contact Us
- 11.3 About Global Markets Direct
- 11.4 Disclaimer
List of Tables
- Table 1: DiaSorin S.p.A,Key Facts
- Table 2: DiaSorin S.p.A Pipeline Products by Equipment Type
- Table 3: DiaSorin S.p.A Pipeline Products By Development Stage
- Table 4: DiaSorin S.p.A Pipeline Products By Therapy Area
- Table 5: DiaSorin S.p.A, Key Employees,
- Table 6: DiaSorin S.p.A, Other Locations
- Table 7: DiaSorin S.p.A, Subsidiaries
List of Figures
- Figure 1: Global Markets Direct Methodology